The genetic landscape of intellectual disability arising from chromosome X

Trends in Genetics

Volumn 25, Issue 7, 2009, Pages 308-316

  Gécz, Jozef ^a,b   Shoubridge, Cheryl ^a,b   Corbett, Mark ^a  

^a Woman's and Children's Hospital   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ANGIOTENSIN 2 RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; FRAGILE X MENTAL RETARDATION PROTEIN; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; IONOTROPIC RECEPTOR; METHYL CPG BINDING PROTEIN 2; NEUROLIGIN; P21 ACTIVATED KINASE 3; RIBOSOME PROTEIN; S6 KINASE; SODIUM PROTON EXCHANGE PROTEIN; SYNAPTOPHYSIN; ZINC FINGER PROTEIN;

GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME; X LINKED MENTAL RETARDATION;

CHROMOSOMES, HUMAN, X; FEMALE; GENETIC VARIATION; HUMANS; MALE; MENTAL RETARDATION, X-LINKED;

EID: 67649921127     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2009.05.002     Document Type: Review

References (100)

1. Leonard H., and Wen X. The epidemiology of mental retardation: challenges and opportunities in the new millennium. Ment. Retard. Dev. Disabil. Res. Rev. 8 (2002) 117-134
2. Kwok H., and Cheung P.W. Co-morbidity of psychiatric disorder and medical illness in people with intellectual disabilities. Curr. Opin. Psychiatry 20 (2007) 443-449
3. Luckasson R. Mental retardation: definition, classification and systems of support (2002), American Association on Mental Retardation
4. Ropers H.H. Genetics of intellectual disability. Curr. Opin. Genet. Dev. 18 (2008) 241-250
5. Rauch A., et al. Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am. J. Med. Genet. A. 140 (2006) 2063-2074
6. Battaglia A. Genetics of mental retardation. Am. J. Med. Genet. C. Semin. Med. Genet. 117C (2003) 1-2
7. Mulley J.C., et al. Nomenclature guidelines for X-linked mental retardation. Am. J. Med. Genet. 43 (1992) 383-391
8. Gécz J. The FMR2 gene. FRAXE and non-specific X-linked mental retardation: clinical and molecular aspects. Ann. Hum. Genet. 64 (2000) 95-106
9. Higgins J.J., and Topaloglu H. X-linked oligophrenic vermian dysgenesis: syndromic vs non-syndromic X-linked mental retardation?. Neurology 65 (2005) 1346-1347
10. Frints S.G., et al. X-linked mental retardation: vanishing boundaries between non-specific (MRX) and syndromic (MRXS) forms. Clin. Genet. 62 (2002) 423-432
11. Turner G. Finding genes on the X chromosome by which homo may have become sapiens. Am. J. Hum. Genet. 58 (1996) 1109-1110
12. Ropers H.H., and Hamel B.C. X-linked mental retardation. Nat. Rev. Genet. 6 (2005) 46-57
13. Zechner U., et al. A high density of X-linked genes for general cognitive ability: a run-away process shaping human evolution?. Trends Genet. 17 (2001) 697-701
14. Graves J.A., et al. Evolution of the human X-a smart and sexy chromosome that controls speciation and development. Cytogenet. Genome Res. 99 (2002) 141-145
15. Chiurazzi P., et al. XLMR genes: update 2007. Eur. J. Hum. Genet. 16 (2008) 422-434
16. Tarpey P.S., et al. A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat. Genet. 41 (2009) 535-543
17. de Brouwer A.P., et al. Mutation frequencies of X-linked mental retardation genes in families from the EuroMRX consortium. Hum. Mutat. 28 (2007) 207-208
18. Hodges E., et al. Genome-wide in situ exon capture for selective resequencing. Nat. Genet. 39 (2007) 1522-1527
19. Gnirke A., et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat. Biotechnol. 27 (2009) 182-189
20. Zahir F., and Friedman J.M. The impact of array genomic hybridization on mental retardation research: a review of current technologies and their clinical utility. Clin. Genet. 72 (2007) 271-287
21. Ballabio A. The rise and fall of positional cloning?. Nat. Genet. 3 (1993) 277-279
22. Van Esch H., et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am. J. Hum. Genet. 77 (2005) 442-453
23. Bauters M., et al. Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repair. Genome Res. 18 (2008) 847-858
24. Sanlaville D., et al. Distal Xq duplication and functional Xq disomy. Orphanet J. Rare Dis. 4 (2009) 4
25. Froyen G., et al. Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation. Am. J. Hum. Genet. 82 (2008) 432-443
26. Solomon N.M., et al. Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3. J. Med. Genet. 41 (2004) 669-678
27. Solomon N.M., et al. Array comparative genomic hybridisation analysis of boys with X-linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3. J. Med. Genet. 44 (2007) e75
28. Stankiewicz P., et al. Duplication of Xq26.2-q27.1, including SOX3, in a mother and daughter with short stature and dyslalia. Am. J. Med. Genet. A. 138 (2005) 11-17
29. Mimault C., et al. Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher Disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. The Clinical European Network on Brain Dysmyelinating Disease. Am. J. Hum. Genet. 65 (1999) 360-369
30. Froyen G., et al. Detection of genomic copy number changes in patients with idiopathic mental retardation by high-resolution X-array-CGH: important role for increased gene dosage of XLMR genes. Hum. Mutat. 28 (2007) 1034-1042
31. Najm J., et al. Mutations of CASK cause an X-linked brain malformation phenotype with microcephaly and hypoplasia of the brainstem and cerebellum. Nat. Genet. 40 (2008) 1065-1067
32. Lugtenberg D., et al. ZNF674: a new kruppel-associated box-containing zinc-finger gene involved in nonsyndromic X-linked mental retardation. Am. J. Hum. Genet. 78 (2006) 265-278
33. Fukami M., et al. A member of a gene family on Xp22.3, VCX-A, is deleted in patients with X-linked nonspecific mental retardation. Am. J. Hum. Genet. 67 (2000) 563-573
34. Lesca G., et al. Xp22.3 microdeletion including VCX-A and VCX-B1 genes in an X-linked ichthyosis family: no difference in deletion size for patients with and without mental retardation. Clin. Genet. 67 (2005) 367-368
35. Mochel F., et al. Normal intelligence and social interactions in a male patient despite the deletion of NLGN4X and the VCX genes. Eur. J. Med. Genet. 51 (2008) 68-73
36. Birney E., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447 (2007) 799-816
37. Chen W., et al. Mutation screening of brain-expressed X-chromosomal miRNA genes in 464 patients with nonsyndromic X-linked mental retardation. Eur. J. Hum. Genet. 15 (2007) 375-378
38. Gécz J. FMR3 is a novel gene associated with FRAXE CpG island and transcriptionally silent in FRAXE full mutations. J. Med. Genet. 37 (2000) 782-784
39. Santos-Reboucas C.B., et al. Lack of FMR3 expression in a male with non-syndromic mental retardation and a microdeletion immediately distal to FRAXE CCG repeat. Neurosci. Lett. 397 (2006) 245-248
40. Ladd P.D., et al. An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum. Mol. Genet. 16 (2007) 3174-3187
41. Khalil A.M., et al. A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome. PLoS One 3 (2008) e1486
42. Gécz J., et al. Identification of the gene FMR2, associated with FRAXE mental retardation. Nat. Genet. 13 (1996) 105-108
43. Bensaid M., et al. FRAXE-associated mental retardation protein (FMR2) is an RNA-binding protein with high affinity for G-quartet RNA forming structure. Nucleic Acids Res. 37 (2009) 1269-1279
44. Sudbrak R., et al. X chromosome-specific cDNA arrays: identification of genes that escape from X-inactivation and other applications. Hum. Mol. Genet. 10 (2001) 77-83
45. Wu Y., et al. Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humans. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 18163-18168
46. Nishimura Y., et al. Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum. Mol. Genet. 16 (2007) 1682-1698
47. Yamanaka S. Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors. Cell Prolif. 41 Suppl 1 (2008) 51-56
48. Koolen D.A., et al. A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nat. Genet. 38 (2006) 999-1001
49. Sharp A.J., et al. Characterization of a recurrent 15q24 microdeletion syndrome. Hum. Mol. Genet. 16 (2007) 567-572
50. Sharp A.J., et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat. Genet. 40 (2008) 322-328
51. Mefford H.C., et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N. Engl. J. Med. 359 (2008) 1685-1699
52. Billuart P., et al. Oligophrenin 1 encodes a rho-GAP protein involved in X-linked mental retardation. Pathol. Biol. (Paris) 46 (1998) 678
53. Allen K.M., et al. PAK3 mutation in nonsyndromic X-linked mental retardation. Nat. Genet. 20 (1998) 25-30
54. D'Adamo P., et al. Mutations in GDI1 are responsible for X-linked non-specific mental retardation. Nat. Genet. 19 (1998) 134-139
55. Merienne K., et al. A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation. Nat. Genet. 22 (1999) 13-14
56. Amir R.E., et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23 (1999) 185-188
57. Orrico A., et al. MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett. 481 (2000) 285-288
58. Carrie A., et al. A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat. Genet. 23 (1999) 25-31
59. Gibbons R.J., and Higgs D.R. Molecular-clinical spectrum of the ATR-X syndrome. Am. J. Med. Genet. 97 (2000) 204-212
60. Yntema H.G., et al. Expanding phenotype of XNP mutations: mild to moderate mental retardation. Am. J. Med. Genet. 110 (2002) 243-247
61. Kutsche K., et al. Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation. Nat. Genet. 26 (2000) 247-250
62. Zemni R., et al. A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat. Genet. 24 (2000) 167-170
63. Hahn K.A., et al. X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28. Am. J. Hum. Genet. 70 (2002) 1349-1356
64. Lebel R.R., et al. Non-syndromic X-linked mental retardation associated with a missense mutation (P312L) in the FGD1 gene. Clin. Genet. 61 (2002) 139-145
65. Strömme P., et al. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat. Genet. 30 (2002) 441-445
66. Kitamura K., et al. Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat. Genet. 32 (2002) 359-369
67. Bienvenu T., et al. ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation. Hum. Mol. Genet. 11 (2002) 981-991
68. Meloni I., et al. FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. Nat. Genet. 30 (2002) 436-440
69. Vervoort V.S., et al. AGTR2 mutations in X-linked mental retardation. Science 296 (2002) 2401-2403
70. Shoichet S.A., et al. Mutations in the ZNF41 gene are associated with cognitive deficits: identification of a new candidate for X-linked mental retardation. Am. J. Hum. Genet. 73 (2003) 1341-1354
71. Kalscheuer V.M., et al. Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation. Nat. Genet. 35 (2003) 313-315
72. Jamain S., et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34 (2003) 27-29
73. Laumonnier F., et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am. J. Hum. Genet. 74 (2004) 552-557
74. Kleefstra T., et al. Zinc finger 81 (ZNF81) mutations associated with X-linked mental retardation. J. Med. Genet. 41 (2004) 394-399
75. Tarpey P., et al. Mutations in the DLG3 gene cause nonsyndromic X-linked mental retardation. Am. J. Hum. Genet. 75 (2004) 318-324
76. Freude K., et al. Mutations in the FTSJ1 gene coding for a novel S-adenosylmethionine-binding protein cause nonsyndromic X-linked mental retardation. Am. J. Hum. Genet. 75 (2004) 305-309
77. Jensen L.R., et al. Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am. J. Hum. Genet. 76 (2005) 227-236
78. Hagens O., et al. Disruptions of the novel KIAA1202 gene are associated with X-linked mental retardation. Hum. Genet. 118 (2006) 578-590
79. Tarpey P.S., et al. Mutations in the gene encoding the Sigma 2 subunit of the adaptor protein 1 complex, AP1S2, cause X-linked mental retardation. Am. J. Hum. Genet. 79 (2006) 1119-1124
80. Klauck S.M., et al. Mutations in the ribosomal protein gene RPL10 suggest a novel modulating disease mechanism for autism. Mol. Psychiatry 11 (2006) 1073-1084
81. Tarpey P.S., et al. Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. Am. J. Hum. Genet. 80 (2007) 345-352
82. Zou Y., et al. Mutation in CUL4B, which encodes a member of cullin-RING ubiquitin ligase complex, causes X-linked mental retardation. Am. J. Hum. Genet. 80 (2007) 561-566
83. Raymond F.L., et al. Mutations in ZDHHC9, which encodes a palmitoyltransferase of NRAS and HRAS, cause X-linked mental retardation associated with a marfanoid habitus. Am. J. Hum. Genet. 80 (2007) 982-987
84. Field M., et al. Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly. Am. J. Hum. Genet. 81 (2007) 367-374
85. Tarpey P.S., et al. Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation. Nat. Genet. 39 (2007) 1127-1133
86. Gilfillan G.D., et al. SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome. Am. J. Hum. Genet. 82 (2008) 1003-1010
87. Molinari F., et al. Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. Am. J. Hum. Genet. 82 (2008) 1150-1157
88. Bick D., et al. Brief report: intragenic deletion of the KALIG-1 gene in Kallmann's syndrome. N. Engl. J. Med. 326 (1992) 1752-1755
89. Maya-Nunez G., et al. Contiguous gene syndrome due to deletion of the first three exons of the Kallmann gene and complete deletion of the steroid sulphatase gene. Clin. Endocrinol. (Oxf.) 48 (1998) 713-718
90. Massin N., et al. X chromosome-linked Kallmann syndrome: clinical heterogeneity in three siblings carrying an intragenic deletion of the KAL-1 gene. J. Clin. Endocrinol. Metab. 88 (2003) 2003-2008
91. Soderlund D., et al. Identification of three novel mutations in the KAL1 gene in patients with Kallmann syndrome. J. Clin. Endocrinol. Metab. 87 (2002) 2589-2592
92. Trarbach E.B., et al. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia. J. Clin. Endocrinol. Metab. 91 (2006) 4006-4012
93. Zhang L., et al. A microdeletion in Xp11.3 accounts for co-segregation of retinitis pigmentosa and mental retardation in a large kindred. Am. J. Med. Genet. A. 140 (2006) 349-357
94. Lugtenberg D., et al. Structural variation in Xq28: MECP2 duplications in 1% of patients with unexplained XLMR and in 2% of male patients with severe encephalopathy. Eur. J. Hum. Genet. 17 (2009) 444-453
95. Willard H.F. X chromosome inactivation and X-linked mental retardation. Am. J. Med. Genet. 64 (1996) 21-26
96. Muers M.R., et al. Defining the cause of skewed X-chromosome inactivation in X-linked mental retardation by use of a mouse model. Am. J. Hum. Genet. 80 (2007) 1138-1149
97. Moretti P., and Zoghbi H.Y. MeCP2 dysfunction in Rett syndrome and related disorders. Curr. Opin. Genet. Dev. 16 (2006) 276-281
98. Crawford J., et al. Mutation screening in Borjeson-Forssman-Lehmann syndrome: identification of a novel de novo PHF6 mutation in a female patient. J. Med. Genet. 43 (2006) 238-243
99. Dibbens L.M., et al. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat. Genet. 40 (2008) 776-781
100. Depienne C., et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet. 5 (2009) e1000381